The Pathophysiology of Scleroderma Involving the Heart and Respiratory System
Authors: MARVIN A. SACKNER
Journal: Annals of Internal Medicine (1964)

Article1 April 1964The Pathophysiology of Scleroderma Involving the Heart and Respiratory SystemMARVIN A. SACKNER, M.D., NECATI AKGUN, M.D., PHILIP KIMBEL, M.D., DAVID H. LEWIS, M.D.MARVIN A. SACKNER, M.D., NECATI AKGUN, M.D., PHILIP KIMBEL, M.D., DAVID H. LEWIS, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-60-4-611 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe lungs from patients with scleroderma show varying degrees of pulmonary fibrosis and medial hypertrophy of the pulmonary arterioles (1). However, little attention has been directed toward the hemodynamics of the pulmonary circulation particularly as related to the parenchymal alterations despite the morphologic observations consistent with pulmonary hypertension. Studies of pulmonary function show restrictive lung disease and impairment of gaseous diffusion, but tightness of the skin over the chest wall and myocardial fibrosis, which have been thought to produce physiologic disturbances, have not been critically evaluated (2-6). The purpose of the following report is to systematically investigate the physiologic nature...References1. MATSUI S: Über die Pathologie und Pathogenese von Sclerodermia universalis. Mitt. Med. Fak. Tokyo 31: 55, 1924. Google Scholar2. BALDWINCOURNANDRICHARDS EDADW: Pulmonary insufficiency. II. A study of thirty-nine cases of pulmonary fibrosis. Medicine 1: 25, 1949. Google Scholar3. MILLERFOWLERHELMHOLZ RDWSFH: Scleroderma of the lungs. Proc. Mayo Clin. 34: 66, 1954. Google Scholar4. ADHIKARIBIANCHIBOUSHYSAKAMOTOLEWIS PKFASFABM: Pulmonary function in scleroderma: its relation to changes in the chest roentgenogram and in the skin of the thorax. Amer. Rev. Resp. Dis. 86: 823, 1962. MedlineGoogle Scholar5. CATTERALLROWELL MNR: Respiratory function in progressive systemic sclerosis. Thorax 18: 10, 1963. CrossrefMedlineGoogle Scholar6. HUGHESLEE DTFI: Lung function in patients with systemic sclerosis. Ibid., 16. Google Scholar7. DUBOISBOTELHOCOMROE ABSYJH: A new method for measuring airway resistance in man using a body Plethysmograph: values in normal subjects and patients with respiratory disease. J. Clin. Invest. 35: 327, 1956. CrossrefMedlineGoogle Scholar8. BEDELLMARSHALLDUBOISCOMROE GNRABJH: Plethysmographic determination of the volume of gas trapped in the lungs. J. Clin. Invest. 35: 664, 1956. CrossrefMedlineGoogle Scholar9. MARSHALLDUBOIS RAB: The viscous resistance of the lung tissue in patients with pulmonary disease. Clin. Sci. 15: 473, 1956. MedlineGoogle Scholar10. MCNEILRANKINFORSTER RSJRE: The diffusing capacity of the pulmonary membrane and the pulmonary capillary blood volume in cardiopulmonary disease. Clin. Sci. 17: 465, 1958. MedlineGoogle Scholar11. DUBOISBOTELHOBEDELLMARSHALLCOMROE ABSYGNRJH: A rapid Plethysmographic method for measuring thoracic gas volume: a comparison with the nitrogen washout method for measuring functional residual capacity in normal subjects. J. Clin. Invest. 35: 322, 1956. CrossrefMedlineGoogle Scholar12. COMROEFORSTERDUBOISBRISCOECARLSEN JHREABWAE: The Lung, 2nd ed., Year Book Publishers, Chicago, 1962. Google Scholar13. COMROEFOWLER JHWS: Lung function studies. VI. Detection of uneven ventilation during a single breath of oxygen: a new test of pulmonary disease. Amer. J. Med. 10: 408, 1951. CrossrefMedlineGoogle Scholar14. MEADWHITTENBERGER JJL: Physical properties of the lungs measured during spontaneous respiration. J. Appl. Physiol. 5: 779, 1953. CrossrefGoogle Scholar15. OGILVIEFORSTERBLAKEMOREMORTON CMREWSJW: A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J. Clin. Invest. 36: 1, 1957. CrossrefMedlineGoogle Scholar16. VAN SLYKENEILL DDJM: Determination of gases in blood and other solutions by vacuum extraction and manometric measurement. J. Biol. Chem. 61: 523, 1924. CrossrefGoogle Scholar17. POLGARFORSTER GRE: Measurement of oxygen tension in unstirred blood with a platinum electrode. J. Appl. Physiol. 15: 706, 1960. CrossrefMedlineGoogle Scholar18. VAN SLYKESENDROY DDJ: Studies of gas and electrolyte equilibria in blood. XV. Line charts for graphic calculations by the Henderson—Hasselbach equation, and for calculating plasma carbon dioxide from whole blood content. J. Biol. Chem. 79: 781, 1928. CrossrefGoogle Scholar19. SEVERINGHAUSBRADLEY JWAF: Electrodes for blood pO2 and pCO2 determination. J. Appl. Physiol. 13: 515, 1958. CrossrefMedlineGoogle Scholar20. SCHOLANDER RF: Analyzer for accurate estimation of respiratory gases in one-half cubic centimeter samples. J. Biol. Chem. 167: 235, 1947. CrossrefMedlineGoogle Scholar21. BALDWINCOURNANDRICHARDS EDADW: Pulmonary insufficiency. I. Physiological classification, clinical methods of analysis, standard values in normal subjects. Medicine 27: 243, 1948. CrossrefMedlineGoogle Scholar22. SANDQVISTKJELLMER LI: Normal values for the single breath nitrogen elimination test in different age groups. Scand. J. Clin. Lab. Invest. 13: 131, 1960. CrossrefGoogle Scholar23. HOLLANDBLACKET RARB: The carbon monoxide diffusing capacity of the lungs in normal subjects. Aust. Ann. Med. 7: 192, 1958. MedlineGoogle Scholar24. GAENSLER EA: Analysis of ventilatory defect by timed vital capacity measurements. Amer. Rev. Tuberc. 64: 256, 1951. Google Scholar25. MARCHLYONS HWHA: A study of the maximum ventilatory flow rates in health and disease. Dis. Chest 37: 3, 1960. Google Scholar26. GAENSLER EA: Air velocity index; a numerical expression of the functionally effective portion of ventilation. Amer. Rev. Tuberc. 62: 17, 1956. Google Scholar27. BRISCOEDUBOIS WAAB: The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size. J. Clin. Invest. 37: 1279, 1958. CrossrefMedlineGoogle Scholar28. MARSHALL R: The physical properties of the lungs in relation to the subdivisions of lung volume. J. Clin. Sci. 16: 507, 1957. MedlineGoogle Scholar29. FRANKMEADFERRIS NRJBG: The mechanical behaviour of the lungs in healthy elderly persons. J. Clin. Invest. 36: 1680, 1957. CrossrefMedlineGoogle Scholar30. BRODYO'HALLORANWANDERCONNOLLY AWPSHJJJ: Measurement of respiratory elastance during passive inflation and of respiratory muscle strength in normal individuals and partially paralyzed postpoliomyelitis patients. Conf. on Resp. Physiol., Nat. Inst. Inf. Paralysis. 1956, p. 47. Google Scholar31. WOOD EH: Normal oxygen saturation of arterial blood during inhalation of air and oxygen. J. Appl. Physiol. 1: 567, 1949. CrossrefMedlineGoogle Scholar32. RAINEBISHOP JMJM: A-a difference in O2 tension and physiological dead space in man. J. Appl. Physiol. 18: 284, 1963. CrossrefMedlineGoogle Scholar33. FISHER RA: Statistical Methods for Research Workers, 12th ed. Oliver and Boyd London, 1954. Google Scholar34. MØLLER B: The hydrogen ion concentration in arterial blood: a clinical study of patients with diabetes mellitus and diseases of the kidneys, lungs, and heart. Acta Med. Scand. Suppl. 348, 1959. Google Scholar35. FOSS O: Sclerodermi med lungefibrose. Nord. Med. 52: 917, 1954. MedlineGoogle Scholar36. CASE 46191. New Eng. J. Med. 262: 981, 1960. CrossrefMedlineGoogle Scholar37. CONNORBASHOUR PKFA: Cardiopulmonary changes in scleroderma: a physiological study. Amer. Heart J. 61: 494, 1961. CrossrefMedlineGoogle Scholar38. SPAINTHOMAS DMAG: The pulmonary manifestations of scleroderma: an anatomic-physiological correlation. Ann. Intern. Med. 32: 152, 1950. LinkGoogle Scholar39. AUSTRIANMCCLEMENTSRENZETTIDONALDRILEYCOURNAND RJHADKWRLA: Clinical and physiological features of some types of pulmonary diseases with impairment of alveolar-capillary diffusion. Amer. J. Med. 11: 667, 1951. CrossrefMedlineGoogle Scholar40. ELLMANCUDKOWICZ PL: Pulmonary manifestations in the diffuse collagen diseases. Thorax 9: 46, 1954. CrossrefMedlineGoogle Scholar41. OPIE L: The pulmonary manifestations of generalized scleroderma (progressive systemic sclerosis). Dis. Chest 28: 665, 1955. CrossrefMedlineGoogle Scholar42. BAUER GE: Scleroderma with heart failure. Aust. Ann. Med. 4: 149, 1955. CrossrefMedlineGoogle Scholar43. FISCHERHANSEN SPF: Diffus myocarditis i indledende stadium of sclerodermi. Nord. Med. 56: 1283, 1956. MedlineGoogle Scholar44. PACEDECKERMARTIN WRJLCJ: Polymyositis: report of two cases with pulmonary function studies suggestive of progressive systemic sclerosis. Amer. J. Med. Sci. 245: 322, 1963. CrossrefGoogle Scholar45. MÜLLER C: Hemodynamics in pulmonary tuberculosis. Acta Chirg. Scand. 119: 309, 1960. MedlineGoogle Scholar46. SVANBORG N: Studies on the cardiopulmonary function in sarcoidosis. III. Cases with fibrosis of the lungs. Acta Med. Scand. Supp. 366: 75, 1961. Google Scholar47. TABAKINHANSONADHIKARINAEYE BSJSPKRL: Circulatory and ventilatory dynamics in alveolar-capillary membrane block. Amer. Rev. Resp. Dis. 83: 194, 1961. MedlineGoogle Scholar48. ZOHMANWILLIAMS LRMH: Cardiopulmonary function in pulmonary fibrosis. Amer. Rev. Resp. Dis. 80: 700, 1959. CrossrefMedlineGoogle Scholar49. HARVEYFERRERRICHARDSCOURNAND RMMIDNA: Influence of chronic pulmonary disease on the heart and circulation. Amer. J. Med. 10: 719, 1951. CrossrefMedlineGoogle Scholar50. HICKAMCARGILL JBNH: Effect of exercise on cardiac output and pulmonary artery pressure in normal persons and in patients with cardiovascular disease and pulmonary emphysema. J. Clin. Invest. 27: 10, 1948. CrossrefMedlineGoogle Scholar51. RILEYHIMMELSTEINMOTLEYWEINERCOURNAND RLAHLHMA: Studies of pulmonary circulation at rest and during exercise in normal individuals and in patients with chronic pulmonary disease. Amer. J. Physiol. 153: 372, 1948. CrossrefGoogle Scholar52. HALMAGYI DF: Role of autonomic nervous system in the genesis of pulmonary hypertension in heart disease. J. Chron. Dis. 9: 525, 1959. CrossrefMedlineGoogle Scholar53. STÁVA Z: The problem of interrelation between diffuse generalized scleroderma, acrosclerosis, Raynaud's phenomenon and Raynaud's disease: a clinical study based on an analysis of 70 cases. Dermatologica 118: 1, 1959. CrossrefGoogle Scholar54. WADEBALL GJ: Unexplained pulmonary hypertension. Quart. J. Med. N.S. 26: 83, 1957. Google Scholar55. RAWSONWOSKE AJHM: A study of etiologic factors in so-called primary pulmonary hypertension. Arch. Intern. Med. (Chicago) 105: 233, 1960. CrossrefMedlineGoogle Scholar56. CELORIAFRIEDELLSOMMERS GCGHSC: Raynaud's disease and primary pulmonary hypertension. Circulation 22: 1055, 1960. CrossrefMedlineGoogle Scholar57. RODNANFENNEL GPPH: Progressive systemic sclerosis sine scleroderma. JAMA 180: 665, 1962. CrossrefMedlineGoogle Scholar58. SOKOLOFF L: Some aspects of the pathology of collagen diseases. Bull. NY Acad. Med. 32: 760, 1956. MedlineGoogle Scholar59. WEISSSTEADWARRENBAILEY SEAJVOT: Scleroderma heart disease: with a consideration of certain other visceral manifestations of scleroderma. Arch. Intern. Med. (Chicago) 71: 749, 1943. CrossrefGoogle Scholar60. ROBINBURWELL EDCS: Hemodynamic aspects of diffuse myocardial fibrosis. Circulation 16: 730, 1957. CrossrefMedlineGoogle Scholar61. RODNANSCHREINERBLACK GPGERL: Renal involvement in progressive systemic sclerosis (generalized scleroderma). Amer. J. Med. 23: 445, 1957. CrossrefMedlineGoogle Scholar62. MARSHALLSMELLIEBAYLISHOYLEBATES RHJHCDV: Pulmonary function in sarcoidosis. Thorax 13: 48, 1958. CrossrefMedlineGoogle Scholar63. RILEYRILEYHILL RLMCHM: Diffuse pulmonary sarcoidosis: diffusing capacity during exercise and other lung function studies in relation to ACTH therapy. Bull. Hopkins Hosp. 91: 345, 1952. MedlineGoogle Scholar64. MEAD J: Control of respiratory frequency. J. Appl. Physiol. 15: 325, 1960. CrossrefGoogle Scholar65. FINLEYSWENSONCOMROE TNEWJH: The cause of arterial hypoxemia at rest in patients with "alveolar capillary block syndrome." J. Clin. Invest. 41: 618, 1962. CrossrefMedlineGoogle Scholar66. LINDERHOLM H: Diffusing capacity of the lungs as a limiting factor for physical working capacity. Acta Med. Scand. 163: 61, 1959. CrossrefMedlineGoogle Scholar67. SUSKINDBRUCEMCDOWELLYULOVEJOY MRAMEPNFW: Normal variations in end-tidal air and arterial blood carbon dioxide and oxygen tensions during moderate exercise. J. Appl. Physiol. 3: 282, 1950. CrossrefMedlineGoogle Scholar68. HUCKABEEJUDSON WEWE: The role of anaerobic metabolism in the performance of mild muscular work. I. Relationship to oxygen consumption and cardiac output and the effect of congestive heart failure. J. Clin. Invest. 37: 1577, 1958. CrossrefMedlineGoogle Scholar69. SACKNERFEISALKARSCH MAKADN: Size of gas exchange vessels in lung. Fed. Proc. 22: 453, 1963. Google Scholar70. SACKNER MA: The visceral manifestations of scleroderma. Arthritis Rheum. 5: 184, 1962. CrossrefMedlineGoogle Scholar71. BERGOFSKYTURINOFISHMAN EHGMAP: Cardiorespiratory failure in kyphoscoliosis. Medicine 38: 263, 1959. CrossrefMedlineGoogle Scholar72. CARODUBOIS CGAB: Pulmonary function in kyphoscoliosis. Thorax 16: 282, 1961. CrossrefMedlineGoogle Scholar73. CAROBUTLERDUBOIS CGJAB: Some effects of restriction of chest wall expansion on pulmonary function in man: an experimental study. J. Clin. Invest. 39: 573, 1960. CrossrefMedlineGoogle Scholar74. NAIMARKCHERNIACK ARM: Compliance of the respiratory system and its components in health and disease. J. Appl. Physiol. 15: 377, 1960. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Philadelphia, PennsylvaniaFrom the Division of Cardiology and Department of Medicine, Philadelphia General Hospital, and the Department of Physiology, Graduate School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.This work was supported in part by U. S. Navy contract NOWR2744, No. 102-470, grant 62-G-123 from the American Heart Association, and grants H 4797 and HE-07415-01 from the United States Public Health Service, Bethesda, Maryland.Presented in part at the Forty-third Annual Session of the American College of Physicians, Philadelphia, Pennsylvania, April, 1962, and at the Nineteenth Annual Meeting of the American Federation for Clinical Research, Atlantic City, New Jersey, April, 1962.Requests for reprints should be addressed to Marvin A. Sackner, M.D., Department of Physiology, Graduate School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySpinal anesthesia for cesarean section in a patient with systemic sclerosis associated interstitial lung disease: a case reportNew Approaches to the Treatment of Pulmonary HypertensionThe Heart in SclerodermaAcute myocardial infarction in systemic sclerosis patients: a case seriesAtypical hemodynamic manifestations of cardiac tamponadePULMONARY FUNCTION TESTS IN INTERSTITIAL LUNG DISEASEDipyridamole stress thallium perfusion scan for evaluating myocardial involvement in systemic sclerosisScleroderma Pericardial Disease Presented with a Large Pericardial EffusionIncreased pulmonary epithelial permeability in systemic sclerosis is associated with enhanced cutaneous nerve growth factor expressionAtteinte pulmonaire au cours de la sclérodermie systémique. Partie II. Hypertension artérielle pulmonaire isolée, cancer bronchopulmonaire, hémorragie alvéolaireQuantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseasesRADIOLOGY OF THE RIGHT VENTRICLEClinical Evaluation of Pulmonary Hypertension in Systemic Sclerosis and Related DisordersRelationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma)MR IMAGING OF PULMONARY HYPERTENSION AND RIGHT VENTRICULAR DYSFUNCTIONLung involvement in SclerodermaInterrelationships Between Pulmonary and Extrapulmonary Involvement in Systemic SclerosisSevere Extrapulmonary Thoracic Restriction Caused by Morphea, a Form of Localized SclerodermaPulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patternsAcute Myocarditis in Fulminant Systemic SclerosisThe Right Ventricle in Pulmonary DiseaseExtrapulmonary Thoracic Restriction (Hidebound Chest) Complicating Eosinophilic FasciitisCardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captoprilInterstitial lung diseaseCardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captoprilDiffusing capacity of the lung and nifedipine in systemic sclerosisThe pulmonary pathologic manifestations of the CREST syndromeCOLD-INDUCED REVERSIBLE MYOCARDIAL ISCHAEMIA IN SYSTEMIC SCLEROSISCase 20-1989Prediction of favourable responses to long term vasodilator treatment of pulmonary hypertension by short term administration of epoprostenol (prostacyclin) or nifedipine.The lungs in systemic sclerosis (scleroderma): A review and new informationManagement of Primary Pulmonary HypertensionCardiopulmonary Manifestations of Systemic SclerosisReversible Cold-Induced Abnormalities in Myocardial Perfusion and Function in Systemic SclerosisELAINE L. ALEXANDER, M.D., Ph.D., GARY S. FIRESTEIN, M.D., JAMES L. WEISS, M.D., RICHARD R. HEUSER, M.D., GEORGE LEITL, M.D., HENRY N. WAGNER Jr., M.D., JEFFREY A. BRINKER, M.D., ALLEN A. CIUFFO, M.D., LEWIS C. BECKER, M.D.Scleroderma and scleroderma-like disordersThe cardiovascular manifestations of systemic sclerosis (scleroderma)Pulmonary hypertension in the crest syndrome variant of systemic sclerosisPulmonary hypertensionNoninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patientsHeart disease in sclerodermaPulmonary involvement in systemic sclerosis (scleroderma)Decreased coronary reserve in primary scleroderma myocardial diseaseMyokarderkrankungenPulmonale Manifestation bei Sklerodermie: Klinische Wertigkeit von Lungenfunktion, bronchoalveolarer Lavage, Ösophagusfunktions- und RES SzintigraphieCarbon monoxide diffusing capacity as predictor of outcome in systemic sclerosisExercise Testing in Interstitial Lung DiseaseLung Involvement in SclerodermaPhysiologic Abnormalities of Cardiac Function in Progressive Systemic Sclerosis with Diffuse SclerodermaPrognosis of Pulmonary Heart DiseasePulmonary Function and Exercise TestingEffect of the Cold Pressor Test on Diffusing CapacityVascular reactivity and pulmonary hypertension in systemic sclerosisAbsence of positional change in pulmonary diffusing capacity in systemic sclerosisPrevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosisProgressive systemische Sklerodermie (Sklerose)Vasodilator therapy of pulmonary hypertension in the crst syndromeCardiovascular function in patients with progressive systemic sclerosis (scleroderma)Serial pulmonary function in systemic sclerosisThe Interstitial Lung Diseases Associated with the Collagen-Vascular DisordersPulmonary VasculitisThe Effect of Cold Exposure on Diffusing Capacity in Patients with Raynaud's PhenomenonPresence of eosinophilia in progressive systemic sclerosis and localized sclerodermaPrimary heart disease in systemic sclerosis (scleroderma): Advances in clinical and pathologic features, pathogenesis, and new therapeutic approachesAssociation of myositis and myocarditis in progressive systemic sclerosisCardiopulmonary Manifestations of Progressive Systemic SclerosisProgressive Systemic Sclerosis: Cardiac InvolvementProgressive Systemic Sclerosis: Pulmonary InvolvementEchocardiographic features of progressive systemic sclerosis (PSS)Pulmonary vascular changes in sclerodermaPulmonary Hypertension in the CREST Syndrome Variant of Progressive Systemic Sclerosis (Scleroderma)ROSEMARIE SALERNI, M.D., GERALD P. RODNAN, M.D., F.A.C.P., DONALD F. LEON, M.D., F.A.C.P., JAMES A. SHAVER, M.D., F.A.C.P.Sclerdderma Kidney Disease: A Therapeutic Approach with Nephrectomy and HemodialysisSkin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositisPericardial fluid analysis in scleroderma (systemic sclerosis)Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.Environmental Factors and the Diffusing Capacity of the Lung in Progressive Systemic SclerosisPathogenesis of systemic sclerosis: A vascular hypothesisPericardial disease in scleroderma (systemic sclerosis)The rheumatic diseases of childhoodZur Morphologie, Biochemie und Funktion der Proteoglycane in der DermatologieSekundäre maligne Tumoren der Bronchien und LungenCase 2-1972Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)WALTER L. NORTON, M.D., F.A.C.P., JOHN M. NARDO, M.D.Uncommon or commonly unrecognized causes of heart failureDiffusionsstörung bei Patienten mit SklerodermieSCLERODERMA: 2. INCIDENCE OF SYSTEMIC DISTURBANCE AND ASSESSMENT OF POSSIBLE ÆTIOLOGICAL FACTORSPathologic observations in systemic sclerosis (scleroderma)Systemic Involvement in the CRST SyndromeResorption of the terminal phalanges in sclerodermaPulmonary SclerodermaPericardial and myocardial disease in progressive systemic sclerosisCase 22-1968AN OBJECTIVE EVALUATION OF THE TREATMENT OF SYSTEMIC SCLERODERMA WITH DISODIUM EDTA, PYRIDOXINE AND RESERPINE*Management of patients with cor pulmonale—Acute and chronicThe Association of Progressive Systemic Sclerosis (Scleroderma) with Coal Miners' Pneumoconiosis and Other Forms of SilicosisGERALD P. RODNAN, M.D., F.A.C.P., THOMAS G. BENEDEK, M.D., THOMAS A. MEDSGER JR., M.D., ROY J. CAMMARATA, M.D.Recent Advances in the Rheumatic DiseasesEPHRAIM P. ENGLEMAN, M.D., F.A.C.P., MARTIN A. SHEARN, M.D., F.A.C.P.Pulmonary hypertension of cardiac and pulmonary originsAnalysis of twenty-seven cases of progressive systemic sclerosis (including two with combined systemic lupus erythematosus) and a review of the literatureSystemic scleroderma with complete heart blockThe heart in sclerodermaEntwicklungslinien der Sklerodermieforschung in der GegenwartRecurrent Spontaneous Pneumothorax in Diffuse SclerodermaCase 51-1965RESPIRATORY FUNCTION STUDIES IN PATIENTS WITH CERTAIN CONNECTIVE TISSUE DISEASES.*Pulmonary Dysfunction in Systemic Lupus Erythematosus 1 April 1964Volume 60, Issue 4Page: 611-630KeywordsHeartHemodynamicsHospital medicineHypertensionLungsPulmonary fibrosisPulmonary hypertensionRespiratory systemSclerodermaThorax ePublished: 1 December 2008 Issue Published: 1 April 1964 PDF downloadLoading ...